Enhanced Therapeutic Potential of Adoptive Immunotherapy by In Vitro CD28/4-1BB Costimulation of Tumor-Reactive T Cells Against a Poorly Immunogenic, Major Histocompatibility Complex Class I-Negative A9P MelanomaScott E. Strome, Lieping Chen, Andrei I. Chapoval et al.|Journal of Immunotherapy|2000Cited by 39
An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and GenomiserIsabelle Cooperstein, Calum A. MacRae, Shruti Marwaha et al.|Genome Medicine|2025Cited by 10